Skip to main content

Table 1 Clinical and hormonal characteristics of the patients with POI

From: Whole-exome sequencing in patients with premature ovarian insufficiency: early detection and early intervention

Case ID

Age (Years)

Menopause

age (Years)

BMI (kg/m2)

Primary or

secondary amenorrhea

FSH (IU/L)

LH (IU/L)

E2 (pg/mL)

Karyotype

Ovary size

(right/ left, mm)

Follicle

POI-1

35

33

25.20

secondary

35.92

16.61

24

46,XX

21*16/22*18

Rare

POI-3

29

27

28.25

secondary

161.18

56.92

21

46,XX

18*11/16*11

Absent

POI-6

30

28

24.14

secondary

73.77

27.56

79

46,XX

19*11/18*12

Absent

POI-7

23

13

23.80

primary

127.54

39.5

34

46,XX

15*10/13*9

Absent

POI-8

25

15

25.71

primary

92.93

43.38

13

46,XX

10*6/11*5

Absent

POI-9

24

18

25.46

secondary

102.8

38.39

 20

46,XX

18*9/21*8

Absent

POI-11

32

31

22.31

secondary

48.65

40.24

18

46,XX

19*12/17*15

Rare

POI-12

28

27

25.65

secondary

86.57

35.77

22

46,XX

16*11/15*9

Rare

POI-14

30

28

22.83

secondary

110.38

51.60

16

46,XX

17*14/16*10

Absent

POI-17

25

24

22.86

secondary

55.24

36.83

15

46,XX

20*14/21*17

Rare

POI-18

27

26

27.55

secondary

60.45

50.46

18

46,XX

18*10/17*8

Rare

POI-21

22

14

23.07

primary

107.28

38.55

24

46,XX

11*6/12*5

Absent

POI-23

26

25

25.81

secondary

38.50

24.69

15

46,XX

17*15/16*13

Rare

POI-24

16

13

24.31

primary

49.66

35.52

33

46,XX

10*5/11*4

Absent

  1. Abbreviation: FSH Follicle-stimulating hormone, LH Luteinizing hormone, E2 Estradiol